193 related articles for article (PubMed ID: 8475106)
1. Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg.
Clark-Lewis I; Dewald B; Geiser T; Moser B; Baggiolini M
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3574-7. PubMed ID: 8475106
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements of platelet chemokines for neutrophil activation.
Yan Z; Zhang J; Holt JC; Stewart GJ; Niewiarowski S; Poncz M
Blood; 1994 Oct; 84(7):2329-39. PubMed ID: 7919350
[TBL] [Abstract][Full Text] [Related]
3. High activity suppression of myeloid progenitor proliferation by chimeric mutants of interleukin 8 and platelet factor 4.
Daly TJ; LaRosa GJ; Dolich S; Maione TE; Cooper S; Broxmeyer HE
J Biol Chem; 1995 Oct; 270(40):23282-92. PubMed ID: 7559482
[TBL] [Abstract][Full Text] [Related]
4. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
Walz A; Dewald B; von Tscharner V; Baggiolini M
J Exp Med; 1989 Nov; 170(5):1745-50. PubMed ID: 2681518
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
[TBL] [Abstract][Full Text] [Related]
6. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor.
Leonard EJ; Yoshimura T; Rot A; Noer K; Walz A; Baggiolini M; Walz DA; Goetzl EJ; Castor CW
J Leukoc Biol; 1991 Mar; 49(3):258-65. PubMed ID: 1997632
[TBL] [Abstract][Full Text] [Related]
7. Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils.
Hébert CA; Luscinskas FW; Kiely JM; Luis EA; Darbonne WC; Bennett GL; Liu CC; Obin MS; Gimbrone MA; Baker JB
J Immunol; 1990 Nov; 145(9):3033-40. PubMed ID: 2212672
[TBL] [Abstract][Full Text] [Related]
8. High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils.
Schumacher C; Clark-Lewis I; Baggiolini M; Moser B
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10542-6. PubMed ID: 1438244
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-activating intercrine secreted by porcine platelets is active without proteolytic processing.
Yan Z; Holt JC; Stewart GJ; Niewiarowski S
Am J Physiol; 1993 Nov; 265(5 Pt 1):C1396-404. PubMed ID: 8238487
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-8 antagonists generated by N-terminal modification.
Moser B; Dewald B; Barella L; Schumacher C; Baggiolini M; Clark-Lewis I
J Biol Chem; 1993 Apr; 268(10):7125-8. PubMed ID: 8463247
[TBL] [Abstract][Full Text] [Related]
11. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.
Webb LM; Ehrengruber MU; Clark-Lewis I; Baggiolini M; Rot A
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7158-62. PubMed ID: 8346230
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil activation by monomeric interleukin-8.
Rajarathnam K; Sykes BD; Kay CM; Dewald B; Geiser T; Baggiolini M; Clark-Lewis I
Science; 1994 Apr; 264(5155):90-2. PubMed ID: 8140420
[TBL] [Abstract][Full Text] [Related]
13. Generation and properties of neutrophil-activating peptide 2.
Walz A
Cytokines; 1992; 4():77-95. PubMed ID: 1472918
[No Abstract] [Full Text] [Related]
14. A molecular switch of chemokine receptor selectivity. Chemical modification of the interleukin-8 Leu25 --> Cys mutant.
Lusti-Narasimhan M; Chollet A; Power CA; Allet B; Proudfoot AE; Wells TN
J Biol Chem; 1996 Feb; 271(6):3148-53. PubMed ID: 8621714
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-activating properties of the melanoma growth-stimulatory activity.
Moser B; Clark-Lewis I; Zwahlen R; Baggiolini M
J Exp Med; 1990 May; 171(5):1797-802. PubMed ID: 2185333
[TBL] [Abstract][Full Text] [Related]
16. Cloning of complementary DNA encoding a functional human interleukin-8 receptor.
Murphy PM; Tiffany HL
Science; 1991 Sep; 253(5025):1280-3. PubMed ID: 1891716
[TBL] [Abstract][Full Text] [Related]
17. Functional and ligand binding specificity of the rabbit neutrophil IL-8 receptor.
Thomas KM; Taylor L; Prado G; Romero J; Moser B; Car B; Walz A; Baggiolini M; Navarro J
J Immunol; 1994 Mar; 152(5):2496-500. PubMed ID: 8133060
[TBL] [Abstract][Full Text] [Related]
18. Chemokine regulation of human megakaryocytopoiesis.
Gewirtz AM; Zhang J; Ratajczak J; Ratajczak M; Park KS; Li C; Yan Z; Poncz M
Blood; 1995 Oct; 86(7):2559-67. PubMed ID: 7670101
[TBL] [Abstract][Full Text] [Related]
19. Ligand selectivity and affinity of chemokine receptor CXCR1. Role of N-terminal domain.
Rajagopalan L; Rajarathnam K
J Biol Chem; 2004 Jul; 279(29):30000-8. PubMed ID: 15133028
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities.
Clark-Lewis I; Schumacher C; Baggiolini M; Moser B
J Biol Chem; 1991 Dec; 266(34):23128-34. PubMed ID: 1744111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
